Barclays
IDXX icon

Barclays’s Idexx Laboratories IDXX Stock Holding History

Barclays’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-92,600
Closed -$38.9M – 5395
2025
Q1 		$38.9M Buy
+92,600
New +$40.2M 0.01% 757
2024
Q4 		– Sell
-103,000
Closed -$52M – 5368
2024
Q3 		$52M Buy
+103,000
New +$50M 0.01% 654
2019
Q1 		– Sell
-200
Closed -$37K – 7147
2018
Q4 		$37K Buy
+200
New +$41K ﹤0.01% 5629
2018
Q3 		– Sell
-7,000
Closed -$1.53M – 7238
2018
Q2 		$1.53M Buy
+7,000
New +$1.44M ﹤0.01% 2822
2017
Q1 		– Sell
-200
Closed -$23K – 6849
2016
Q4 		$23K Buy
+200
New +$22.8K ﹤0.01% 5552

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Barclays's IDXX Position: Q2 2026 in Review

Barclays reduced its Idexx Laboratories (IDXX) stake by 21% in Q2 2026, selling an estimated $21.8M and leaving 148,839 shares worth $78.4M. The position accounts for 0.02% of the portfolio, ranked #581.

Barclays first reported a position in IDXX in Q2 2013 and has held it in 53 quarters since. The position peaked at $229M in Q3 2024. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Barclays held 148,839 shares of Idexx Laboratories worth $78.4M as of Q2 2026.
  • Barclays sold 38,876 Idexx Laboratories shares in Q2 2026, an estimated $21.8M.
  • Idexx Laboratories made up 0.02% of Barclays's portfolio in Q2 2026, its #581 holding.
  • Barclays first reported a position in Idexx Laboratories in Q2 2013 and has held it in 53 quarters since.
  • Barclays's Idexx Laboratories position peaked at $229M in Q3 2024.
  • 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.